Zinc takes the center stage: Its paradoxical role in Alzheimer's disease

Brain Research Reviews

Volumn 41, Issue 1, 2003, Pages 44-56

  Cuajungco, Math P ^a,b,d   Fagét, Kyle Y ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRYN MAWR COLLEGE   (United States)

^d Harvard Institute for Human Genetics   (United States)

Author keywords

Alzheimer's disease; Copper; Oxidative stress; Zinc

Indexed keywords

AMYLOID BETA PROTEIN; METAL CHELATE; ZINC;

ALZHEIMER DISEASE; CYTOTOXICITY; DRUG MECHANISM; HYPOTHESIS; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOLOGY; PRIORITY JOURNAL; PROTEIN METABOLISM; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BRAIN; CHELATING AGENTS; COPPER; HUMANS; OXIDATIVE STRESS; ZINC;

EID: 0037219351     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(02)00219-9     Document Type: Review

References (161)

1. Ancsin J.B., Kisilevsky R. Laminin interactions important for basement membrane assembly are promoted by zinc and implicate laminin zinc finger-like sequences. J. Biol. Chem. 271:1996;6845-6851.
2. Araki W., Kitaguchi N., Tokushima Y., Ishii K., Aratake H., Shimohama S., Nakamura S., Kimura J. Trophic effect of β-amyloid precursor protein on cerebral cortical neurons in culture. Biochem. Biophys. Res. Commun. 181:1991;265-271.
3. Atwood C.S., Scarpa R.C., Huang X., Moir R.D., Jones W., Fairlie D.P., Tanzi R.E., Bush A.I. Characterization of copper interactions with Alzheimer amyloid β peptides: identification of an attomolar-affinity copper binding site on amyloid β1-42. J. Neurochem. 75:2000;1219-1233.
4. Atwood C.S., Moir R.D., Huang X., Bacarra N.M.E., Scarpa R.C., Romano D.M., Hartshorn M.A., Tanzi R.E., Bush A.I. Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis. J. Biol. Chem. 273:1998;12817-12826.
5. Atwood C.S., Huang X., Khatri A., Scarpa R.C., Kim Y.S., Moir R.D., Tanzi R.E., Roher A.E., Bush A.I. Copper catalyzed oxidation of Alzheimer Aβ Cell Mol. Biol. (Noisy-le-grand). 6:2000;777-783.
6. Basun H., Forssell L.G., Wetterberg L.G., Winblad B. Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease. J. Neural Trans. Parkinson's Dis. Dementia. 3:1991;231-258.
7. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid-β protein toxicity. Cell. 77:1994;817-827.
8. Bertram L., Blacker D., Mullin K., Keeney D., Jones J., Basu S., Yhu S., McInnis M.G., Go R.C.P., Vekrellis K., Selkoe D.J., Saunders A.J., Tanzi R.E. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science. 290:2000;2302-2303.
9. Bhatia R., Lin H., Lal R. Fresh and globular amyloid β protein (1-42) induces rapid cellular degeneration: evidence for Aβ channel-mediated cellular toxicity. FASEB J. 14:2000;1233-1243.
10. Blacker D., Wilcox M.A., Laird N.M., Rodes L., Horvath S.M., Go R.C.P., Perry R., Watson B. Jr., Basset S.S., McInnis M.G., Albert M.S., Hyman B.T., Tanzi R.E. α2-Macroglobulin is genetically associated with Alzheimer's disease. Nature Genet. 19:1998;357-360.
11. Borchardt T., Schmidt C., Camarkis J., Cappai R., Masters C.L., Beyreuther K., Multhaup G. Differential effects of zinc on amyloid precursor protein (APP) processing in copper-resistant variants of cultured Chinese hamster ovary cells. Cell. Mol. Biol. (Noisy-le-grand). 46:2000;785-795.
12. Bray T.M., Bettger W.J. The physiological role of zinc as an antioxidant. Free Rad. Biol. Med. 8:1990;281-291.
13. Brown A.M., Tummolo D.M., Thodes K.J., Hofmann J.R., Jacobsen J.S., Sonnenberg-Reines J. Selective aggregation of endogenous β-amyloid peptide and soluble amyloid precursor protein in cerebrospinal fluid by zinc. J. Neurochem. 69:1997;1204-1212.
14. K.M. Brown, J.M. Lee, L. Wei, D.W. Choi, Accumulation of intracellular free zinc in degenerating neurons following mild transient focal ischemia in mice lacking the ZnT3 gene. Soc. Neurosci. Abstracts, (2001) 868.14.
15. Bruce A.J., Malfroy B., Baudry M. β-Amyloid toxicity in organotypic hippocampal cultures: protection by Euk-8, a synthetic catalytic free radical scavenger. Proc. Natl. Acad. Sci. USA. 93:1996;2312-2316.
16. Burnet F.M. A possible role of zinc in the pathology of dementia. Lancet. 1:1981;186-188.
17. Bush A.I., Multhaup G., Moir R.D., Small D.H., Rumble B., Pollwein P., Beyreuther K., Masters C.L. A novel zinc(II) binding site modulates the function of the βA4 amyloid protein precursor of Alzheimer's disease. J. Biol. Chem. 268:1993;16109-16112.
18. Bush A.I., Moir R.D., Rosenkranz K.M., Tanzi R.E. Zinc and Alzheimer's disease. Science. 268:1995;1921-1923.
19. Bush A.I., Pettingell W.H., Multhaup G., Paradis M.D., Vonsattel J.P., Gusella J.F., Beyreuther K., Masters C.L., Tanzi R.E. Rapid induction of Alzheimer Aβ amyloid formation by zinc. Science. 265:1994;1464-1467.
20. Bush A.I., Pettingell W.H., Paradis M.D., Tanzi R.E. The amyloid-β protein precursor and its mammalian homologues. Evidence for a zinc-modulated heparin-binding superfamily. J. Biol. Chem. 269:1994;26618-26621.
21. Butterfield D.A., Hensley K., Harris M., Mattson M.P., Carney J. β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200:1994;710-715.
22. S.M. Cardoso, A.C. Rego, C.R. Oliveira, The role of zinc on amyloid β-mediated toxicity, Soc. Neurosci. Abstracts, (2001) 322.8.
23. Chartier-Harlin M.C., Crawford F., Houlden H. Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature. 353:1991;844-846.
24. Checler F. Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease. J. Neurochem. 65:1995;1431-1444.
25. Cherny R.A., Atwood C.S., Xilinas M.E., Gray D.N., Jones W.D., McLean C.A., Barnham K.J., Volitakis I., Fraser F.W., Kim Y., Huang X., Goldstein L.E., Moir R.D., Lim J.T., Beyreuther K., Zheng H., Tanzi R.E., Masters C.L., Bush A.I. Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron. 30:2001;665-676.
26. Cherny R.A., Legg J.T., McLean C.A., Fairlie D.P., Huang X., Atwood C.S., Beyreuther K., Tanzi R.E., Masters C.L., Bush A.I. Aqueous dissolution of Alzheimer's disease Aβ amyloid deposits by biometal depletion. J. Biol. Chem. 274:1999;23223-23228.
27. Choi D.W., Yokoyama M., Koh J. Zinc neurotoxicity in cortical cell culture. Neuroscience. 24:1988;67-79.
28. Citron M., Westaway D., Xia W., Carlson G., Diehl T., Levesque G., Johnson-Wood K., Lee M., Seubert P., Davis A., Kholodenko D., Motter R., Sherrington R., Perry B., Yao H., Strome R., Lieberburg I., Rommens J., Kim S., Schenk D., Fraser P., St George Hyslop P., Selkoe D.J. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nature Med. 3:1997;67-72.
29. Colvin R.A., Smith M.B., Bowman L., Gillum J.M. pH dependence of zinc transport and compartmentalization of zinc in rat cortical neurons. Am. J. Cell. Physiol. 282:2001;C317-329.
30. Constantinidis J. The hypothesis of zinc deficiency in the pathogenesis of neurofibrillary tangles. Med. Hypoth. 35:1991;319-323.
31. Cornett C.R., Markesbery W.R., Ehmann W.D. Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. Neurotoxicology. 19:1998;339-345.
32. Corrigan F.M., Reynolds G.P., Ward N.I. Hippocampal tin, aluminum, and zinc in Alzheimer's disease. Biometals. 6:1993;149-154.
33. Crapper-McLachlan D.R., Dalton A.J., Kruck T.P.A., Bell M.Y., Smith W.L., Kalow W., Andrews D.F. Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet. 337:1991;1304-1308.
34. M.P. Cuajungco, The Involvement of Zinc in Alzheimer's Disease, Ph.D. Thesis, 1999, University of Auckland, New Zealand.
35. Cuajungco M.P., Lees G.J. Prevention of zinc neurotoxicity in vivo by N,N,N′,N′-tetrakis (2-pyridylmethyl) ethylenediamine (TPEN). NeuroReport. 7:1996;1301-1304.
36. Cuajungco M.P., Lees G.J. Zinc metabolism in the brain: relevance to human neurodegenerative disorders. Neurobiol. Dis. 4:1997;137-169.
37. Cuajungco M.P., Lees G.J. Zinc and Alzheimer's disease: is there a direct link? Brain Res. 799:1997;97-107.
38. Cuajungco M.P., Lees G.J. Diverse effects of metal chelating agents on the neuronal cytotoxicity of zinc in the hippocampus. Brain Res. 799:1998;97-107.
39. Cuajungco M.P., Lees G.J. Nitric oxide generators produce accumulation of chelatable zinc in hippocampal neuronal perikarya. Brain Res. 799:1998;118-129.
40. Cuajungco M.P., Goldstein L.E., Nunomura A., Smith M.A., Lim J.T., Atwood C.S., Huang X., Farrag Y.W., Perry G., Bush A.I. Evidence that the β-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of Aβ by zinc. J. Biol. Chem. 275:2000;19439-19442.
41. Cuajungco M.P., Faget K.Y., Huang X., Tanzi R.E., Bush A.I. Metal chelation as a potential therapy for Alzheimer's disease. Ann. NY Acad. Sci. 920:2000;292-304.
42. Curtain C.C., Ali F., Volitakis I., Cherny R.A., Norton R.S., Beyreuther K., Barrow C.J., Masters C.L., Bush A.I., Barnham K.J. Alzheimer's disease amyloid-β binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J. Biol. Chem. 276:2001;20466-20473.
43. Dandrea M.R., Reiser P.A., Gumula N.A., Hertzog B.M., Andrade-Gordon P. Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease. Biotech. Histochem. 76:2001;97-106.
44. Danscher G., Jensen K.B., Frederickson C.J., Kemp K., Andreasen A., Juhl S., Stoltenbert M., Ravid R. Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains: a proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material. J. Neurosci. Methods. 76:1997;53-59.
45. Davies P., Maloney A.J.F. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet. 2:1976;1403.
46. Deibel M.A., Ehmann W.D., Markesbery W.R. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J. Neurol. Sci. 143:1996;137-142.
47. Drachman D., Leavitt J. Human memory and the cholinergic system. Arch. Neurol. 30:1974;113-121.
48. Dwork A.J., Schon E.A., Herbert J. Nonidentical distribution of transferrin and ferric iron in human brain. Neuroscience. 27:1988;333-345.
49. Emre M., Geula C., Ransil B.J., Mesulam M.M. The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected β-amyloid in the rat brain. Neurobiol. Aging. 13:1992;553-559.
50. Ertekin-Taner N., Graff-Radford N., Younkin L.H., Eckman C., Baker M., Adamson J., Ronald J., Blangero J., Hutton M., Younkin S.G. Linkage of plasma Aβ42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science. 290:2000;2303-2304.
51. Esler W.P., Stimson E.R., Jennings J.M., Ghilardi J.R., Mantyh P.W., Maggio J.E. Zinc-induced aggregation of human and rat β-amyloid peptides in vitro. J. Neurochem. 66:1996;723-732.
52. Frederickson C.J. Neurobiology of zinc and zinc-containing neurons. Int. Rev. Neurobiol. 31:1989;145-238.
53. Fuson K.S., Boggs L.N., May P.C. Zinc promotes Aβ aggregation but attenuates Aβ neurotoxicity. Neurobiol. Aging. 17:(Suppl.):1996;431.
54. Fuson K.S., Boggs L.N., May P.C. Zinc attenuates amyloid β (Aβ)1-40 neurotoxicity. Soc. Neurosci. Abstr. 22:1996;195.
55. Glenner G.G., Wong C. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120:1984;885-890.
56. Golde T.E., Younkin S.G. Presenilins as therapeutic targets for the treatment of Alzheimer's disease. Trends Mol. Med. 7:2001;264-269.
57. Gonzalez C., Martin T., Cacho J., Brenas M.T., Arroyo T., Garcia-Berrocal B., Navajo J.A., Gonzalez-Buitrago J.M. Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers. Eur. J. Clin. Invest. 29:1999;637-642.
58. Gray D.N., Cherny R.A., Masters C.L., Tanzi R.E., Bush A.I. Resolubilization of Alzheimer and APP transgenic β-amyloid plaque by copper chelators. Soc. Neurosci. Abstracts. 24:1998;722.
59. Halliwell B., Gutteridge J.M.C. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 219:1984;1-14.
60. Halliwell B., Clement M.V., Ramalingam J., Long L.H. Hydrogen peroxide. Ubiquitous in cell culture and in vivo? IUBMB Life. 50:2000;251-257.
61. Hesse L., Beher D., L Masters C., Multhaup G. The β A4 amyloid precursor protein binding to copper. FEBS Lett. 349:1994;109-116.
62. Hirakura Y., Yiu W.W., Yamamoto A., Kagan B.L. Amyloid peptide channels: blockade by zinc and inhibition by Congo red (amyloid channel block). Amyloid. 7:2000;194-199.
63. Huang X., Atwood C.S., Hartshorn M.A., Multhaup G., Goldstein L.E., Scarpa R.C., Cuajungco M.P., Gray D.N., Lim J., Moir R.D., Tanzi R.E., Bush A.I. The Aβ peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry. 38:1999;7609-76016.
64. Huang X., Atwood C.S., Moir R.D., Hartshorn M.A., Vonsattel J.P., Tanzi R.E., Bush A.I. Zinc-induced Alzheimer's Aβ1-40 aggregation is mediated by conformational factors. J. Biol. Chem. 272:1997;26464-26470.
65. Huang X., Cuajungco M.P., Atwood C.S., Hartshorn M.A., Tyndall J., Hanson G.R., Stokes K.C., Leopold M., Multhaup G., Goldstein L.E., Scarpa R.C., Saunders A.J., Lim J., Moir R.D., Glabe C., Bowden E.F., Masters C.L., Fairlie D.P., Tanzi R.E., Bush A.I. Alzheimer Aβ interaction with Cu(II) induces neurotoxicity, radicalization, metal reduction and cell-free hydrogen peroxide formation. J. Biol. Chem. 274:1999;37111-37116.
66. Huber G., Bailly Y., Martin J.R., Mariani J., Brugg B. Synaptic β-amyloid precursor proteins increase with learning capacity in rats. Neuroscience. 80:1997;313-320.
67. Hyman B.T., Van Hoesen G.W., Kroner L.J., Damasio A.R. Perforant pathway changes and the memory impairment in Alzheimer's disease. Ann. Neurol. 20:1986;472-481.
68. Kalaria R.N., Bhatti S.U., Palatinsky E.A., Pennington D.H., Shelton E.R., Chan H.W., Perry G., Lust W.D. Accumulation of the β amyloid precursor protein at sites of ischemic injury in rat brain. NeuroReport. 4:1993;211-214.
69. Koh J.Y., Suh S.W., Gwag B.J., He Y.Y., Hsu C.Y., Choi D.W. The role of zinc in selective neuronal death after transient global cerebral ischemia. Science. 272:1996;1013-1016.
70. Kozin S.A., Zirah S., Rebuffat S., Hoa G.H., Debey P. Zinc binding to Alzheimer's Aβ (1-16) peptide results in stable soluble complex. Biochem. Biophys. Res. Commun. 285:2001;959-964.
71. Kurochkin I.V., Goto S. Alzheimer's β-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett. 345:1994;33-37.
72. Lee J.Y., Mook-Jung I., Koh J.Y. Histochemically reactive zinc in plaques of the Swedish mutant β-amyloid precursor protein transgenic mice. J. Neurosci. 19:1999;RC10.
73. Lee J.Y., Cole T.B., Palmiter R.D., Koh J.Y. Accumulation of zinc in degenerating hippocampal neurons of ZnT3-null mice after seizures: evidence against synaptic vesicle origin. J. Neurosci. 20:2000;RC79.
74. Lemere C.A., Blusztajn J.K., Yamaguchi H., Wisniewski T., Saido T.C., Selkoe D.J. Sequence of deposition of heterogeneous amyloid β-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol. Dis. 3:1996;16-32.
75. Levy-Lahad E., Wijsman E.M., Nemens E., Anderson L., Goddard K.A.B., Weber J.L., Bird T.D., Schellenberg G.D. A familial Alzheimer's disease locus on chromosome 1. Science. 269:1995;970-973.
76. Li Q.X., Evin G., Small D.H., Multhaup G., Beyreuther K., Masters C.L. Proteolytic processing of Alzheimer's disease β A4 amyloid precursor protein in human platelets. J. Biol. Chem. 270:1995;14140-14147.
77. 2+. J Neurosci. 21:2001;8015-8025.
78. 2+ from presynaptic terminals into postsynaptic hippocampal neurons after physiological stimulation. J. Neurophysiol. 86:2001;2597-2604.
79. 2+-sensitive channel in reconstituted lipid vesicles. Biochemistry. 38:1999;11189-11196.
80. Liu S.T., Howlett G., Barrow C.J. Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the Aβ peptide of Alzheimer's disease. Biochemistry. 38:1999;9373-9378.
81. Loeffler D.A., Lewitt P.A., Juneau P.L., Sima A.A., Nguyen H.U., Demaggio A.J., Brickman C.M., Brewer G.J., Dick R.D., Troyer M.D., Kanaley L. Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders. Brain Res. 738:1996;265-274.
82. Lorenzo A., Yankner B.A. β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA. 91:1994;12243-12247.
83. Loske C., Gerdemann A., Schepl W., Wycislo M., Schinzel R., Palm D., Riederer P., Munch G. Transition metal-mediated glycoxidation accelerates crosslinking of β-amyloid peptide. Eur. J. Biochem. 267:2000;4171-4178.
84. Lovell M.A., Xie C., Markesbery W.R. Protection against amyloid-β peptide toxicity by zinc. Brain Res. 823:1999;88-95.
85. Lovell M.A., Robertson J.D., Teesdale W.J., Campbell J.L., Markesbery W.R. Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158:1998;47-52.
86. Lue L.F., Kuo Y.M., Roher A.E., Brachova L., Shen Y., Sue L., Beach T., Kurth J.H., Rydel R.E., Rogers J. Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155:1999;853-862.
87. Mantyh P.W., Ghilardi J.R., Rogers S., DeMaster E., Allen C.J., Stimson E.R., Maggio J.E. Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of β-amyloid peptide. J. Neurochem. 61:1993;1171-1174.
88. Mason R.P., Jacob R.F., Walter M.F., Mason P.E., Avdulov N.A., Chochina S.V., Igbavboa U., Wood W.G. Distribution and fluidizing action of soluble and aggregated amyloid β-peptide in rat synaptic plasma membranes. J. Biol. Chem. 274:1999;18801-18807.
89. Masters C.L., Multhaup G., Simms G., Pottgiesser J., Martins R.N., Beyreuther K. Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J. 4:1985;2757-2763.
90. Matsuoka Y., Picciano M., Malester B., LaFrancois J., Zehr C., Daeschner J.M., Olschowka J.A., Fonseca M.I., O'Banion M.K., Tenner A.J., Lemere C.A., Duff K. Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease. Am. J. Pathol. 158:2001;1345-1354.
91. May P.C., Boggs L.N., Zhang Z., Drzewiecke G.J., Hyslop P.A., Fuson K.S. Zinc interferes with Aβ(1-40) deposition onto cultured neurons: correlation with neuroprotection. Soc. Neurosci. Abstr. 22:1996;196.
92. McGeer P.L., Schulzer M., McGeer E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology. 47:1996;425-432.
93. McLean C.A., Cherny R.A., Fraser F.W., Fuller S.J., Smith M.J., Beyreuther K., Bush A.I., Masters C.L. Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann. Neurol. 46:1999;860-866.
94. Mecocci P., MacGarvey U., Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36:1994;747-751.
95. Milne D.B., Davis C.D., Nielsen F.H. Low dietary zinc alters indices of copper function and status in postmenopausal women. Nutrition. 17:2001;701-708.
96. Miura T., Suzuki K., Kohata N., Takeuchi H. Metal binding modes of Alzheimer's amyloid-β peptide in insoluble aggregates and soluble complexes. Biochemistry. 39:2000;7024-7031.
97. Moir R.D., Atwood C.S., Romano D.M., Laurans M.H., Huang X., Smith J.D., E Tanzi R. Differential effects of apolipoprotein E isoforms on metal-induced aggregation of Aβ using physiological concentrations. Biochemistry. 38:1999;4595-4603.
98. Molina J.A., Jimenez-Jimenez F.J., Aguilar M.V., Meseguer I., Mateos-Vega C.J., Gonzalez-Munoz M.J., de Bustos F., Porta J., Orti-Pareja M., Zurdo M., Barrios E., Martinez-Para M.C. Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. J. Neural Transm. 105:1998;479-488.
99. Monji A., Utsumi H., Ueda T., Imoto T., Yoshida I., Hashioka S., Tashiro K., Tashiro N. The relationship between the aggregational state of the amyloid-β peptides and free radical generation by the peptides. J. Neurochem. 77:2001;1425-1432.
100. Moreira P., Pereira C., Santos M.S., Oliveira C. Effect of zinc ions on the cytotoxicity induced by the amyloid-β peptide. Antioxid. Redox Signal. 2:2000;317-325.
101. Mucke L., Masliah E., Yu G.Q., Mallory M., Rockenstein E.M., Tatsuno G., Hu K., Kholodenko D., Johnson-Wood K., McConlogue L. High-level neuronal expression of aβ 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20:2000;4050-4058.
102. Multhaup G., Ruppert T., Schlicksupp A., Hesse L., Bill E., Pipkorn R., Masters C.L., Beyreuther K. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I). Science. 271:1996;1406-1409.
103. Multhaup G., Bush A.I., Pollwein P., Masters C.L. Interaction between the zinc(II) and the heparin binding site of the Alzheimer's disease A4β amyloid precursor protein. FEBS Lett. 355:1994;151-154.
104. Multhaup G., Ruppert T., Schlicksupp A., Hesse L., Bill E., Pipkorn R., Masters C.L., Beyreuther K. Copper-binding amyloid precursor protein undergoes a site-specific fragmentation in the reduction of hydrogen peroxide. Biochemistry. 37:1998;7224-7230.
105. Murrell J., Ghetti B., Benson M. A mutation in the amyloid precursor protein associated with Alzheimer's disease. Science. 254:1991;97-99.
106. Myers A., Holmans P., Marshall H., Kwon J., Meyer D., Ramic D., Shears S., Booth J., DeVrieze F.W., Crook R., Hamshere M., Abraham R., Tunstall N., Rice F., Carty S., Lillystone S., Kehoe P., Rudrasingham V., Jones L., Lovestone S., Perez-Tur J., Williams J., Owen M.J., Hardy J., Goate A.M. Susceptibility locus for Alzheimer's disease on chromosome 10. Science. 290:2000;2304-2305.
107. Narindrasorasak S., Altman R.A., Gonzales-DeWhitt P., Greenberg B.D., Kisilevsky R. An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease. Lab. Invest. 72:1995;272-282.
108. Narindrasorasak S., Lowery D.E., Altman R.A., Gonzales-DeWhitt P., Greenberg B.D., Kisilevsky R. Characterization of high affinity binding between laminin and Alzheimer's disease amyloid precursor proteins. Lab. Invest. 67:1992;643-652.
109. Pike C.J., Walencewicz A.J., Glabe C.G., Cotman C.W. Aggregation-related toxicity of synthetic β-amyloid protein in hippocampal cultures. Eur. J. Pharmacol. 207:1991;367-368.
110. Plantin L.O., Lying-Tunell U., Kristensson K. Trace elements in the human nervous system studied with Neutron activation analysis. Biol. Trace Elem. 13:1987;69-75.
111. Plassman B.L., Havlik R.J., Steffens D.C., Helms M.J., Newman T.N., Drosdick D., Phillips C., Gau B.A., Welsh-Bohmer K.A., Burke J.R., Guralnik J.M., Breitner J.C. Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias. Neurology. 55:2000;1158-1166.
112. Potocnik F.C., van Rensburg S.J., Park C., Taljaard J.J.F., Emsley R.A. Zinc and platelet membrane microviscosity in Alzheimer's disease: the in vivo effect of zinc on platelet membranes and cognition. S. Afr. Med. J. 87:1997;1116-1119.
113. Powell S.R. The antioxidant properties of zinc. J. Nutr. 130:(Suppl.):2000;1447S-1454S.
114. Price D.L., Davis P.B., Morris J.C., White D.L. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol. Aging. 12:1991;295-312.
115. Ramirez M.J., Heslop K.E., Francis P.T., Rattray M. Expression of amyloid precursor protein, tau and presenilin RNAs in rat hippocampus following deafferentation lesions. Brain Res. 907:2001;222-232.
116. Regland B., Lehmann W., Abedini I., Blennow K., Jonsson M., Karlsson I., Sjogren M., Wallin A., Xilinas M., Gottfries C.G. Treatment of Alzheimer's disease with clioquinol. Dement. Geriatr. Cogn. Disord. 12:2001;408-414.
117. 2+-sensitive channel. J. Biol. Chem. 273:1998;13379-13382.
118. Roberts S.B., Ripellino J.A., Ingalls K.M., Robakis N.K., Felsentein K.M. Nonamyloidogenic cleavage of the β-amyloid precursor protein by an integral membrane metalloendopeptidase. J. Biol. Chem. 269:1994;3111-3116.
119. Robinson S.R., Noone D.F., Kril J., Halliday G.M. Most amyloid plaques contain ferritin-rich cells. Alzheimer's Res. 1:1995;191-196.
120. Rottkamp C.A., Raina A.K., Zhu X., Gaier E., Bush A.I., Atwood C.S., Chevion M., Perry G., Smith M.A. Redox-active iron mediates amyloid-β toxicity. Free Radic. Biol. Med. 30:2001;447-450.
121. Ruiz F.H., Gonzalez M., Bodini M., Opazo C., Inestrosa N.C. Cysteine 144 is a key residue in the copper reduction by the β-amyloid precursor protein. J. Neurochem. 73:1999;1288-1292.
122. Rulon L.L., Robertson J.D., Lovell M.A., Deibel M.A., Ehmann W.D., Markesbery W.R. Serum zinc levels and Alzheimer's disease. Biol. Trace Elem. Res. 75:2000;79-85.
123. Samudralwar D.L., Diprete C.C., Ni B.F., Ehmann W.D., Markesbery W.R. Elemental imbalances in the olfactory pathway in Alzheimer's disease. J. Neurol. Sci. 130:1995;139-145.
124. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C.W., Pfeiffer E., Schneider L.S., Thal L.J. A controlled trial of selegiline, α-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. New Engl. J. Med. 336:1997;1216-1222.
125. Saunders A.M., Strittmatter W.J., Schmechel D., St. George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., Hulette C., Crain B., Goldgaber D., Roses A.D. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
126. Sayre L.M., Perry G., Harris P.L., Liu Y., Schubert K.A., Smith M.A. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J. Neurochem. 74:2000;270-279.
127. Schubert D., Chevion M. The role of iron in β amyloid toxicity. Biochem. Biophys. Res. Commun. 216:1995;702-707.
128. D.J. Selkoe, M.B. Podlisny, A. Gronbeck, A. Mammen, K.S. Kosik, Molecular relation of amyloid filaments and paired helical filaments in Alzheimer's disease, R.J. Wurtman, S. Corkin, J.H. Growdon, E. Ritter-Walker Advances in Neurology, Raven Press, New York, 1990, pp. 171-179.
129. 2+-permeable AMPA/kainate channels triggers prolonged mitochondrial superoxide production. Proc. Natl. Acad. Sci. USA. 96:1999;2414-2419.
130. Sherrington R., Rogaev E.I., Liang Y., Rogaev E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J.F., Bruni A.C., Montesi M.P., Sorbi S., Rainero I., Pinessi L., Polinsky R.J., Wasco W., Da Silva A.R., Haines J.L., Pericak-Vance M.A., Tanzi R.E., Roses A.D., Fraser P.E., Rommens J.M., St. George-Hyslop P.H. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;755-760.
131. Shoham S., Ebstein R.P. The distribution of β-amyloid precursor protein in rat cortex after systemic kainate-induced seizures. Exp. Neurol. 147:1997;361-376.
132. Smith M.A., Harris P.L.R., Sayre L.M., Perry G. Iron accumulation in Alzheimer's disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. USA. 94:1997;9866-9868.
133. Smith A., Hirai K., Hsiao K., Pappolla M.A., Harris P.L.R., Siedlak S., Tabaton M., Perry G. Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress. J. Neurochem. 70:1998;2212-2215.
134. Smith M.A., Sayre L.M., Anderson V.E., Harris P.L.R., Beal M.F., Kowall N., Perry G. Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine. J. Histochem. Cytochem. 46:1998;731-735.
135. Smith M.A., Richey P.L., Taneda S., Kutty R.K., Sayre L.M., Monnier V.M., Perry G. Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease. Ann. NY Acad. Sci. 738:1994;447-454.
136. Smith M.A., Harris P.L.R., Sayre L.M., Beckman J.S., Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 17:1997;2653-2657.
137. Smith R.M. Copper in the developing brain. Droste T.E., Smith R.M. Neurobiology of Trace Elements. Vol. 1:1983;1-40 Humana Press, Clifton, NJ.
138. St. Croix C.M., Wasserloos K.J., Dineley K.E., Reynolds I.J., Levitan E.S., Pitt B.R. Nitric oxide-induced changes in intracellular zinc homeostasis are mediated by metallothionein/thionein. Am. J. Physiol. Lung Cell. Mol. Physiol. 282:2002;L185-L192.
139. Suh S.W., Chen J.W., Motamedi M., Bell B., Listiak K., Pons N.F., Danscher G., Frederickson C.J. Evidence that synaptically-released zinc contributes to neuronal injury after traumatic brain injury. Brain Res. 852:2000;268-273.
140. Suh S.W., Jensen K.B., Jensen M.S., Silva D.S., Kesslak P.J., Danscher G., Frederickson C.J. Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains. Brain Res. 852:2000;274-278.
141. Sundberg R.J., Martin R.B. Interactions of histidine and other imidazole derivatives with transition metal ions in chemical and biological systems. Chem. Rev. 74:1974;471-517.
142. Suzuki K., Miura T., Takeuchi H. Inhibitory effect of copper(II) on zinc(II)-induced aggregation of amyloid β-peptide. Biochem. Biophys. Res. Commun. 285:2001;991-996.
143. Tamaoka A., Sawamura N., Fukushima T., Shoji S., Matsubara E., Shoji M., Hirai S., Furiya Y., Endoh R., Mori H. Amyloid β protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease. J. Neurol. Sci. 148:1997;41-45.
144. Thompson C.M., Markesbery W.R., Ehmann Y., Mao X., Vance D.E. Regional brain trace element studies in Alzheimer's disease. Neurotoxicology. 9:1988;1-7.
145. Tully C.L., Snowdon D.A., Markesbery W.R. Serum zinc, senile plaques, and neurofibrillary tangles: findings from the Nun study. NeuroReport. 6:1995;2105-2108.
146. Uryu K., Laurer H., McIntosh T., Pratico D., Martinez D., Leight S., Lee V.M., Trojanowski J.Q. Repetitive mild brain trauma accelerates Aβ deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis. J. Neurosci. 22:2002;446-454.
147. Van Nostrand W.E. Zinc (II) selectively enhances the inhibition of coagulation factor XIa by protease nexin-2/amyloid β-protein precursor. Thromb. Res. 78:1995;43-53.
148. Van Rhijn A.G., Prior C.A., Corrigan F.M. Dietary supplementation with zinc sulphate, sodium selenite and fatty acids in early dementia of Alzheimer's type. J. Nutr. Med. 1:1990;259-266.
149. Wang J., Dickson D.W., Trojanowski J.Q., Lee V.M. The levels of soluble versus insoluble brain Aβ distinguish Alzheimer's disease from normal and pathologic aging. Exp. Neurol. 158:1999;328-337.
150. Wang R.J., Nixon B.R. Identification of hydrogen peroxide as a photoproduct toxic to human cells in tissue-culture medium irradiated with 'daylight' fluorescent light. In Vitro. 14:1978;715-722.
151. Wasco W., Bupp K., Magendantz M., Gusella J.F., Tanzi R.E., Solomon F. Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer's disease-associated β precursor protein. Proc. Natl. Acad. Sci. USA. 89:1992;10758-10762.
152. Wasco W., Gurubhagavatula S., Paradis M.D., Romano D.M., Sisodia S.S., Hyman B.T., Neve R.L., Tanzi R.E. Isolation and characterization of the human APLP2 gene encoding a homologue of the Alzheimer's associated amyloid β protein precursor. Nature Genet. 5:1993;95-100.
153. Weldon D.T., Rogers S.D., Ghilardi J.R., Finke M.P., Cleary J.P., O'Hare E., Esler W.P., Maggio J.E., Mantyh P.W. Fibrillar β-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J. Neurosci. 18:1998;2161-2217.
154. White A.R., Bush A.I., Beyreuther K., Masters C.L., Cappai R.
155. Whitemore P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., DeLong M.R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 215:1982;1237-1239.
156. Yang D.S., McLaurin J., Qin K., Westaway D., Fraser P.E. Examining the zinc binding site of the amyloid-β peptide. Eur. J. Biochem. 267:2000;6692-6698.
157. Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science. 250:1990;279-282.
158. Yates C.M., Butterworth J., Tennant M.C., Gordon A. Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias. J. Neurochem. 55:1990;1624-1630.
159. Yoshiike Y., Tanemura K., Murayama O., Akagi T., Murayama M., Sato S., Sun X., Tanaka N., Takashima A. New insights on how metals disrupt amyloid β-aggregation and their effects on amyloid-β cytotoxicity. J. Biol. Chem. 276:2001;32293-32299.
160. Zago M.P., Oteiza P.I. The antioxidant properties of zinc: interactions with iron and antioxidants. Free Radic. Biol. Med. 31:2001;266-274.
161. Zhu Y.J., Lin H., Lal R. Fresh and nonfibrillar amyloid β protein(1-40) induces rapid cellular degeneration in aged human fibroblasts: evidence for Aβ-channel-mediated cellular toxicity. FASEB J. 14:2000;1244-1254.